{"product_id":"oncology-based-in-vivo-cro-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eOncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e \n\n\u003cp\u003eThe global oncology based in-vivo CRO market size reached US$ 1.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eOncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.\u003c\/p\u003e\n\n\u003cp\u003eOncology Based In-Vivo CRO Market Trends:\u003c\/p\u003e\n\n\u003cp\u003eThe growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R\u0026amp;D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eIMARC Group provides an analysis of the key trends in each sub-segment of the global oncology based in-vivo CRO market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on indication, model and application.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Indication:\u003c\/p\u003e\n\n\u003cp\u003eBlood Cancer\u003cbr\u003e\nSolid Tumors\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Model:\u003c\/p\u003e\n\n\u003cp\u003eSyngeneic\u003cbr\u003e\nXenograft\u003cbr\u003e\nPatient Derived Xenograft (PDX)\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Application:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nRehabilitation Centers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003c\/p\u003e\n\n \u003cp\u003eUnited States\u003cbr\u003e\n Canada\u003c\/p\u003e\n\n\u003cp\u003eAsia-Pacific\u003c\/p\u003e\n\n \u003cp\u003eChina\u003cbr\u003e\n Japan\u003cbr\u003e\n India\u003cbr\u003e\n South Korea\u003cbr\u003e\n Australia\u003cbr\u003e\n Indonesia\u003cbr\u003e\n Others\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003c\/p\u003e\n\n \u003cp\u003eGermany\u003cbr\u003e\n France\u003cbr\u003e\n United Kingdom\u003cbr\u003e\n Italy\u003cbr\u003e\n Spain\u003cbr\u003e\n Russia\u003cbr\u003e\n Others\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003c\/p\u003e\n\n \u003cp\u003eBrazil\u003cbr\u003e\n Mexico\u003cbr\u003e\n Others\u003c\/p\u003e\n\n\u003cp\u003eMiddle East and Africa\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003c\/p\u003e\n\n\u003cp\u003eThe competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003c\/p\u003e\n\n\u003cp\u003eWhat was the size of the global oncology based in-vivo CRO market in 2022?\u003c\/p\u003e\n\n\u003cp\u003eWhat is the expected growth rate of the global oncology based in-vivo CRO market during 2023-2028?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the key factors driving the global oncology based in-vivo CRO market?\u003c\/p\u003e\n\n\u003cp\u003eWhat has been the impact of COVID-19 on the global oncology based in-vivo CRO market?\u003c\/p\u003e\n\n\u003cp\u003eWhat is the breakup of the global oncology based in-vivo CRO market based on the indication?\u003c\/p\u003e\n\n\u003cp\u003eWhat is the breakup of the global oncology based in-vivo CRO market based on the model?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the key regions in the global oncology based in-vivo CRO market?\u003c\/p\u003e\n\n\u003cp\u003eWho are the key players\/companies in the global oncology based in-vivo CRO market?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 142 Pages \/ MCW16236882","offer_id":47652302094642,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/oncology-based-in-vivo-cro-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}